Product Information
MESALAMINE ER 0.375 GRAM CAP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.4979 per EA under NDC 59651039708. Its NADAC has been published 147 times since Sep 6, 2023.
Strength
.375 g/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651039708
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA214477On Market Since
3/31/2023
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE ER 0.375 GRAM CAP has been published 147 times since Sep 6, 2023, and over the history we have for it it has declined 52.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4979 per EA |
|---|---|
| All-time high | $1.0513 (Sep 13, 2023) |
| All-time low | $0.4196 (Feb 18, 2026) |
| 52-week high | $0.4979 |
| 52-week low | $0.4196 |
| Median price | $0.4926 |
| Average price | $0.5714 |
| Largest weekly change | -38.7% (Jul 17, 2024) |
| Weeks tracked | 147 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE ER 0.375 GRAM CAP?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE ER 0.375 GRAM CAP, manufactured by Aurobindo Pharma Limited, is $0.4979 per EA (NDC 59651039708), effective Jun 24, 2026.
How has the price of MESALAMINE ER 0.375 GRAM CAP changed over time?
Over the history we have for it, the NADAC for MESALAMINE ER 0.375 GRAM CAP has declined 52.6%. It has been tracked across 147 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for MESALAMINE ER 0.375 GRAM CAP?
Since Sep 6, 2023, the NADAC for MESALAMINE ER 0.375 GRAM CAP has ranged from a low of $0.4196 (Feb 18, 2026) to a high of $1.0513 (Sep 13, 2023), with a median of $0.4926 per EA.
Are there cheaper alternatives to MESALAMINE ER 0.375 GRAM CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE ER 0.375 GRAM CAP, but none are currently priced below it.
Who manufactures MESALAMINE ER 0.375 GRAM CAP?
MESALAMINE ER 0.375 GRAM CAP (NDC 59651039708) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification